5th Annual
Advances in Immuno-Oncology Congress24 - 25 August 2020 | BST (UTC+1)
Advances in Immuno-Oncology Congress24 - 25 August 2020 | BST (UTC+1)
An outstanding and comprehensive programme showcasing the key therapeutic strategies and technological advances impacting this marketplace
The Advances in Immuno-Oncology Congress includes...
Over 350 attendees representing global pharmaceutical organisations, leading biotech companies and internationally renowned academic and healthcare institutions developing immuno-oncology therapies and tools
Over 60 presentations, case studies and panel discussions focussed on the key opportunities and challenges in immuno-oncology, from therapeutic strategies and biomarker development through to clinical research
PLUS interactive opportunities including:
- Workshop on Accelerating the Treatment & Response Rate of Cancer Immunotherapies
- 6 roundtable discussions on key industry growth areas within immuno-oncology
Agenda at a Glance
Day OneĀ
- Discovery of Immuno-Oncology Therapies: Inhibitory Pathway & Cell-Based Approaches
- Translational Immuno-Oncology
- Personalised Therapies for Immuno-Oncology
Day Two
- Discovery of Immuno-Oncology Therapies: Antibody and Virus-Based Approaches
- Preclinical Development: Screening, Assays and Modelling in Immuno-Oncology
- Clinical Research & Trials in Immuno- Oncology